Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 1/20 | 0.35 |
| ▸ | TRDMT1 | O14717 | 1/20 | 0.35 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | NNMT | P40261 | 1/20 | 0.35 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6895651 | 0.99 | AHCY (0.35) | AHCYTRDMT1CARM1NNMTDOT1L | |
| SCHEMBL7914645 | 0.90 | TRDMT1 (0.37) | AHCYTRDMT1CARM1NNMTDOT1L | |
| SCHEMBL5501797 | 0.89 | CARM1 (0.33) | TRDMT1CARM1NNMTDOT1L | |
| SCHEMBL2109084 | 0.88 | TRDMT1 (0.36) | AHCYTRDMT1CARM1NNMTDOT1L | |
| SCHEMBL4557136 | 0.88 | NNMT (0.34) | TRDMT1CARM1NNMTDOT1L | |
| SCHEMBL7050370 | 0.87 | NNMT (0.34) | TRDMT1CARM1NNMTDOT1L | |
| SCHEMBL7922845 | 0.87 | CARM1 (0.33) | TRDMT1CARM1NNMTDOT1L | |
| SCHEMBL7920985 | 0.87 | P2RX3 (0.33) | AHCYTRDMT1CARM1NNMTDOT1L | |
| SCHEMBL15879332 | 0.87 | TRDMT1 (0.36) | AHCYTRDMT1CARM1NNMTDOT1L | |
| SCHEMBL1582963 | 0.86 | TRDMT1 (0.34) | AHCYTRDMT1CARM1NNMTDOT1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0604409-B1 | OLIGONUCLEOTIDE ANALOGS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION | ISIS PHARMACEUTICALS INC (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-1418179-A2 | Compositions and methods for detecting and modulating rna activity and gene expression | ISIS PHARMACEUTICALS, INC. (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030187240-A1 | 2' -modified oligonucleotides | ISIS PHARMACEUTICALS, INC. | 2003-10-02 | — | — | US | disclosed |
| US-20030004325-A1 | Sugar modified oligonucleotides | ISIS PHARMACEUTICALS, INC. | 2003-01-02 | — | — | US | disclosed |